Medical Properties Trust, Inc.

MPT Real Estate Reit Healthcare Facilities

Medical Properties Trust, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $972.0 million, down 2.36% from fiscal 2024.

Revenue
+5.31%
EPS
+360.3%
Free cash flow
−15.2%
Total debt
−3.70%

Quarter to September 2026, against a year earlier

1.80 0.08 −4.26%
Market cap
$1.1B
P/E
4.3×
Fwd P/E
15.0×
Dividend yield
20.0%
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Insider Decisions last twelve months

Bought, $m 0.01
Sold, $m 0.01
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — 1 — — —
Sell 1 — — — — — — — — — — —
Insider Ownership 17.94%

Capital & Financial Ratios $m

Size
Market Cap 1,120.00
Revenue ttm 1,031.83
Net income ttm (29.03)
Free cash flow ttm 258.79
Net debt Q 8,660.98
Valuation
P/E 4.34
Forward P/E 15.00
Price / sales 1.04
Forward P/S Powerpack
Price / FCF 4.15
Price / book 0.23
Financial health
Current ratio Q 3.92
Debt / equity Q 2.00
Interest coverage Q 2.18
Growth
Revenue growth Q +5.31% (above 0%: growing)
Operating income growth Q −59.77% (below 0%: shrinking)
EPS, this year +124.09% (at or above 15%: strong)
EPS, next year A −156.82% (below 0%: weak)
Revenue, next year A +2.01%
EPS, past 5 yrs —
EPS, next 5 yrs A +29.37% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/E against its own 10 years 0.05%
10-year low 10-year high
P/S against its own 10 years 0.04%
10-year low 10-year high
P/B against its own 10 years 0.04%
10-year low 10-year high
EV/Sales against its own 10 years 4.11%
10-year low 10-year high
EV/FCF against its own 10 years 81.30%
10-year low 10-year high

Dividends

Yield
20.0%
Annual rate
0.36
Payout ratio
86.8%
Growth, 2017–25
−12.5%/yr
  1. 0.96 ’17
  2. 1.00 ’18 +4
  3. 1.02 ’19 +2
  4. 1.08 ’20 +6
  5. 1.12 ’21 +4
  6. 1.16 ’22 +4
  7. 0.88 ’23 −24
  8. 0.46 ’24 −48
  9. 0.33 ’25 −28
  10. 0.36 ’26e +9
paid forecast change on the year, % Powerpack

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 250 332 541 599
Receivables 681 737 901 963
Inventory — — — —
Other — — — —
931 1,069 1,442 1,563
2023 2024 2025 Q'26
Payables 412 454 549 399
ST’ Debt — — — —
Other — — — —
412 454 549 399

Compound Annual Growth %

10y 5y 3y
Sales 8.20% (4.89%) (14.27%)
Cash Flow 1.09% (17.87%) (32.16%)
Earnings 0.00% 0.00% 0.00%
Book Value 8.14% (8.90%) (18.77%)

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 0.05 0.00 0.34 — —
’25 (0.20) (0.16) (0.13) 0.03 (0.46)
’24 (1.46) (0.54) (1.34) (0.69) (4.02)
’23 0.05 (0.07) 0.19 (1.11) (0.93)
’22 1.05 0.32 0.37 (0.24) 1.50
’21 0.28 0.19 0.29 0.34 1.11
’20 0.15 0.21 0.25 0.20 0.81
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 252 259 250 — —
’25 224 240 238 270 972
’24 271 267 226 232 996
’23 350 337 307 (122) 872
’22 410 400 352 380 1,543
’21 363 382 391 409 1,545
’20 294 292 329 334 1,249
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (14) 62 — — —
’25 0 52 19 160 231
’24 74 35 59 77 245
’23 136 77 158 135 506
’22 179 165 214 181 739
’21 189 177 212 234 812
’20 107 182 153 175 618
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (8) 55 — — —
’25 (6) 65 47 164 271
’24 51 1,527 289 153 2,020
’23 122 551 206 410 1,289
’22 1,855 216 575 170 2,815
’21 190 179 245 376 990
’20 117 251 167 108 643
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

3.1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 541 705 785 854 1,249 1,545 1,543 872 996 972 1,032 +6.7% 992 1,063 1,079 +3.5%
Gross margin, % 99.50 99.18 98.82 97.19 98.01 97.47 97.04 95.23 97.26 96.25 95.92 (3.2) pt
EBT 219 294 1,019 374 463 731 960 (687) (2,364) (237) 246 n/m
EBT margin, % 40.49 41.71 129.94 43.76 37.09 47.32 62.20 (78.78) (237.48) (24.41) 23.87 (64.9) pt
Net income 226 291 1,018 376 432 657 904 (556) (2,408) (276) (29) n/m
Per share, $
Per share, $ Revenue 2.08 2.01 2.15 2.00 2.36 2.62 2.58 1.46 1.66 1.62 1.73 (2.7%)
Earnings 0.86 0.82 2.77 0.88 0.81 1.11 1.50 (0.93) (4.02) (0.46) 0.41 n/m
Cash flow 1.01 1.04 1.23 1.16 1.17 1.38 1.23 0.85 0.41 0.38 0.00 (10.2%)
Capex 0.11 (0.03) 4.00 0.07 0.05 0.30 3.47 1.31 2.96 0.07 0.00 (4.9%)
Free cash flow 1.12 1.01 5.22 1.22 1.22 1.68 4.70 2.15 3.36 0.45 0.00 (9.6%)
Book value 12.49 10.96 12.48 16.46 13.88 14.34 14.36 12.75 8.05 7.67 7.74 (5.3%)
Shares, m 260 350 365 427 529 589 599 599 600 601 598 +9.7%
Valuation, ×
Valuation, × P/E 13.97 16.87 5.81 24.55 26.90 21.48 7.69 0.00 0.00 0.00 4.34 11.7
P/S 5.98 6.87 7.49 10.55 9.23 9.01 4.47 3.47 2.38 3.09 1.04 6.3
P/B 1.00 1.26 1.29 1.28 1.57 1.65 0.80 0.40 0.49 0.65 0.23 1.0
EV/Sales 11.20 13.57 10.93 15.98 14.99 16.01 10.98 14.73 10.94 12.51 9.44 13.2
EV/FCF 20.81 27.12 4.49 37.78 29.10 24.98 6.02 9.96 5.39 44.82 37.62 21.0
Cash, $m
Cash, $m Operating cash flow 264 362 449 494 618 812 739 506 245 231 227 (1.5%)
Capex 28 (9) 1,460 28 26 179 2,076 783 1,774 41 32 +4.4%
Free cash flow 291 353 1,909 522 643 990 2,815 1,289 2,020 271 259 (0.8%)
Balance, $m
Balance, $m Working capital 50 225 1,383 2,463 1,771 636 569 519 615 892 1,164 +37.7%
Net debt 2,826 4,727 2,696 4,634 7,192 10,824 10,033 9,814 8,516 9,157 8,661 +14.0%
Shareholders’ equity 3,253 3,835 4,561 7,028 7,344 8,446 8,594 7,634 4,834 4,607 4,622 +3.9%
Returns, %
Returns, % ROA 3.74 3.75 11.38 3.21 2.76 3.51 4.49 (2.93) (14.79) (1.89) 1.70 (5.6) pt
ROIC 1.87 2.25 2.91 1.84 2.15 2.18 2.16 (1.18) (0.15) 0.13 0.18 (1.7) pt
ROE 8.40 8.18 24.22 6.47 6.00 8.31 10.59 (6.86) (38.66) (5.87) 5.37 (14.3) pt
People
People Employees 54 66 77 86 106 112 119 121 118 121 — +9.4%
Revenue/emp, $m 10.02 10.68 10.19 9.93 11.79 13.79 12.97 7.20 8.44 8.03 — (2.4%)
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 2 Nov 2026

Medical Properties Trust, Inc. vs peers in Reit Healthcare Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
NHI National Health Investors, Inc. $3.5B 20.5× 16.5× +33.81% (above 0%: growing) +45.57% (above 0%: growing) +2,585.45% (above 0%: growing) 72.18% 41.09% Compare
LTC LTC Properties, Inc. $2.6B 4.6× 23.6× +66.32% (above 0%: growing) n/m −126.46% (below 0%: shrinking) 100.00% 303.46% Compare
DHC Diversified Healthcare Trust $1.7B — (loss-making) 8.4× −5.41% (below 0%: shrinking) n/m +100.70% (above 0%: growing) 21.97% (3.97%) Compare
MPT Medical Properties Trust, Inc. $1.1B 4.3× 15.0× +5.31% (above 0%: growing) n/m −15.15% (below 0%: shrinking) 95.44% (5.49%)
NHP National Healthcare Properties, Inc. $1.1B — (loss-making) — (loss-making) +19.80% (above 0%: growing) n/m +119.70% (above 0%: growing) 0.00% 30.87% Compare
STRW Strawberry Fields REIT, Inc. $695.6M 54.1× 18.8× +0.70% (above 0%: growing) n/m +129.47% (above 0%: growing) 0.00% 58.43% Compare
UHT Universal Health Realty Income Trust $542.8M 26.9× 31.2× +0.17% (above 0%: growing) +22.69% (above 0%: growing) −69.28% (below 0%: shrinking) 94.23% 35.35% Compare
XRN Chiron Real Estate Inc. $430.6M 8.3× 9.4× +8.34% (above 0%: growing) n/m −25.21% (below 0%: shrinking) 100.00% 0.00% Compare
CHCT Community Healthcare Trust Incorporated $423.6M 19.6× 36.8× +4.37% (above 0%: growing) +277.67% (above 0%: growing) +151.08% (above 0%: growing) 81.58% 35.78% Compare
Median of peers $902.8M 20.0× 18.8× +6.36% +45.57% +110.20% 76.88% 35.57%

All 17 Reit Healthcare Facilities stocks →

Pay and ownership Proxy statement filed 13 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 15.90m 16.61m 37.95
2024 16.39m 17.14m 28.07
2023 17.85m 1.21m 31.62
2022 16.03m (8.73m) 63.54
2021 17.04m 33.68m 124.60

Ownership

Directors and executive officers, together 1.84%
The Vanguard Group, Inc. 11.54%
BlackRock Inc. 11.26%
Daniel Yet 8.51%
Zhengxu He 6.80%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Medical Properties Trust, Inc. (MPT) Latest News

29 Oct

Impact 4 · · The Motley Fool transcript
Impact 4 · · Business Wire
Impact 3 · · Associated Press

17 Aug

Impact 4 · · The Motley Fool transcript

30 Apr

Impact 3 · · Business Wire
stockrow.com/MPT · Data as of Nov 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com